Health Dictionary Find a Doctor

Myasthenia gravis history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

History: Female Gender, african/Americans race, evidence of coexisting autoimmune diseases, a positive history of: Heavy eyelids and double vision , eye movement problems

Photophobia , facial weakness, tongue weakness, chewing and swallowing problems, respiratory problems, limbs muscles weakness, Fatigue and urinary incontinency.symptoms: Ptosis and diplopia, gaze paralysis, photophobia, facial weakness, orbicularis oculi weakness, tongue weakness (chewing problems and dysphagia), respiratory problems, limbs muscles weakness, fatigue and pelvic floor weakness.

History and Symptoms

History

Common symptoms

  • tongue weakness, chewing problems and dysphagia
    • The muscles of the tongue will become weak in MG patients especially after long speech. This can lead to unintelligible speech and dysphasia. Difficulty in swallowing can cause choking and nasal regurgitation. Furthermore the weakness of mastication muscles will cause chewing problem and can lead to weight loss.[9][10]
  • Respiratory problems
    • Inability to maintain a patent airway or respiratory insufficiency can occur in MG patients especially those who are in the MG crises.[11]
    • Respiratory problems can cause inadequate sleep and day time somnolence.[12]

Less common symptoms

References

  1. ↑ Alkhawajah NM, Oger J (November 2013). “Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing”. Muscle Nerve. 48 (5): 705–10. doi:10.1002/mus.23964. PMIDΒ 23893883.
  2. ↑ Phillips LH, Torner JC, Anderson MS, Cox GM (October 1992). “The epidemiology of myasthenia gravis in central and western Virginia”. Neurology. 42 (10): 1888–93. PMIDΒ 1407568.
  3. ↑ Oh SJ, Morgan MB, Lu L, Hatanaka Y, Hemmi S, Young A, Claussen GC (March 2009). “Racial differences in myasthenia gravis in Alabama”. Muscle Nerve. 39 (3): 328–32. doi:10.1002/mus.21191. PMCΒ 2814330. PMIDΒ 19127534.
  4. ↑ Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A (June 2003). “Clinical aspects of MuSK antibody positive seronegative MG”. Neurology. 60 (12): 1978–80. PMIDΒ 12821744.
  5. ↑ 5.0 5.1 Osher RH, Glaser JS (March 1980). “Myasthenic sustained gaze fatigue”. Am. J. Ophthalmol. 89 (3): 443–5. PMIDΒ 7369304.
  6. ↑ 6.0 6.1 Spooner JW, Baloh RW (January 1979). “Eye movement fatigue in myasthenia gravis”. Neurology. 29 (1): 29–33. PMIDΒ 570673.
  7. ↑ 7.0 7.1 Lepore FE, Sanborn GE, Slevin JT (July 1979). “Pupillary dysfunction in myasthenia gravis”. Ann. Neurol. 6 (1): 29–33. doi:10.1002/ana.410060107. PMIDΒ 228589.
  8. ↑ 8.0 8.1 Patten BM (1978). “Myasthenia gravis: review of diagnosis and management”. Muscle Nerve. 1 (3): 190–205. doi:10.1002/mus.880010304. PMIDΒ 86952.
  9. ↑ 9.0 9.1 De Assis JL, Marchiori PE, Scaff M (1994). “Atrophy of the tongue with persistent articulation disorder in myasthenia gravis: report of 10 patients”. Auris Nasus Larynx. 21 (4): 215–8. PMIDΒ 7779022.
  10. ↑ 10.0 10.1 Oosterhuis H, Bethlem J (April 1973). “Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study”. J. Neurol. Neurosurg. Psychiatry. 36 (2): 244–54. PMCΒ 1083560. PMIDΒ 4708458.
  11. ↑ 11.0 11.1 Keesey JC (July 2002). “Crisis” in myasthenia gravis: an historical perspective”. Muscle Nerve. 26 (1): 1–3. doi:10.1002/mus.10095. PMIDΒ 12115943.
  12. ↑ 12.0 12.1 Keesey JC (November 1999). “Does myasthenia gravis affect the brain?”. J. Neurol. Sci. 170 (2): 77–89. PMIDΒ 10561522.
  13. ↑ 13.0 13.1 Jablecki C, Benton A (1982). “The frequency of muscle involvement in myasthenia gravis correlates with mean muscle temperature”. Muscle Nerve. 5 (6): 491–2. PMIDΒ 6290881.
  14. ↑ 14.0 14.1 Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, Whitaker JN (June 1982). “A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel”. Ann. Neurol. 11 (6): 553–69. doi:10.1002/ana.410110603. PMIDΒ 6287911.
  15. ↑ 15.0 15.1 Oh SJ, Kuruoglu R (June 1992). “Chronic limb-girdle myasthenia gravis”. Neurology. 42 (6): 1153–6. PMIDΒ 1603341.
  16. ↑ 16.0 16.1 Nations SP, Wolfe GI, Amato AA, Jackson CE, Bryan WW, Barohn RJ (February 1999). “Distal myasthenia gravis”. Neurology. 52 (3): 632–4. PMIDΒ 10025802.
  17. ↑ 17.0 17.1 Ochs CW, Bradley RJ, Katholi CR, Byl NN, Brown VM, Jones LL, Shohet JS (1998). “Symptoms of patients with myasthenia gravis receiving treatment”. J Med. 29 (1–2): 1–12. PMIDΒ 9704288.
  18. ↑ 18.0 18.1 Greene LF, Ghosh MK, Howard FM (August 1974). “Transurethral prostatic resection in patients with myasthenia gravis”. J. Urol. 112 (2): 226–7. PMIDΒ 4843338.
  19. ↑ 19.0 19.1 Wise GJ, Gerstenfeld JN, Brunner N, Grob D (August 1982). “Urinary incontinence following prostatectomy in patients with myasthenia gravis”. Br J Urol. 54 (4): 369–71. PMIDΒ 6180793.
  20. ↑ 20.0 20.1 Silvestri NJ, Wolfe GI (July 2012). “Myasthenia gravis”. Semin Neurol. 32 (3): 215–26. doi:10.1055/s-0032-1329200. PMIDΒ 23117946.
  21. ↑ 21.0 21.1 Keesey JC (April 2004). “Clinical evaluation and management of myasthenia gravis”. Muscle Nerve. 29 (4): 484–505. doi:10.1002/mus.20030. PMIDΒ 15052614.
  22. ↑ 22.0 22.1 Keesey J, Buffkin D, Kebo D, Ho W, Herrmann C (1981). “Plasma exchange alone as therapy for myasthenia gravis”. Ann. N. Y. Acad. Sci. 377: 729–43. PMIDΒ 6951497.
  23. ↑ Roberts ME, Steiger MJ, Hart IK (January 2002). “Presentation of myasthenia gravis mimicking blepharospasm”. Neurology. 58 (1): 150–1. PMIDΒ 11781428.

Template:WH Template:WS

Β© 2026 MyEClinic – IFTM Institut fΓΌr Telematik in der Medizin GmbH